Spaulding Clinical Research, a West Bend-based clinical research and medical device company, today announced that the company tripled its fiscal yearly revenues for 2012.
“Our customer retention and the ability to attract new Sponsors demonstrate Spaulding Clinical’s commitment to delivering the highest-quality, on-time study results for every study. This is also reflected in our high net promoter score,” said Daniel Selness, general manager and senior vice president of clinical research at Spaulding.
Randy Spaulding, founder and chief executive officer of Spaulding Clinical, said, “Our vision for speed and results has been demonstrated again this year by more sponsors benefiting from the value of our customized Clinical Pharmacology electronic data capture (EDC) solution. With bi-directional interfaces to clinical lab results, bedside devices and telemetry, all phase I study data seamlessly transfer into the Medidata Rave EDC or any requested clinical data management system. Spaulding’s value to clients is realized by not only saving time but also through the virtual elimination of data transcription errors.”
Spaulding Clinical Research operates a 105-bed clinical pharmacology unit with 96 telemetry beds in West Bend.
